IDEAYA Biosciences, Inc. (IDYA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 696.11M | 666.73M | 802.65M | 685.6M | 707.87M | 689.71M | 932.21M | 713.18M | 709.35M | 532.63M | 482.18M | 501.79M |
| Cash & Short-Term Investments | 671.2M | 639.39M | 786.89M | 669.74M | 692.51M | 676.32M | 920.03M | 701.66M | 698.77M | 525.11M | 468.75M | 493.72M |
| Cash Only | 157.52M | 112.83M | 298.93M | 114.64M | 130M | 84.38M | 400.28M | 183.05M | 108.34M | 157.02M | 151.85M | 102.84M |
| Short-Term Investments | 513.68M | 526.56M | 487.97M | 555.09M | 562.51M | 591.94M | 519.75M | 518.61M | 590.43M | 368.1M | 316.9M | 390.87M |
| Accounts Receivable | 0 | 5.97M | 0 | 0 | 0 | 3K | 20K | 1K | 15K | 18K | 6.7M | 160K |
| Days Sales Outstanding | - | 50.53 | - | - | - | 0.15 | - | - | - | 78.81 | 39.28 | 8.06 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 24.91M | 21.37M | 0 | 15.86M | 15.36M | 13.39M | 12.16M | 11.52M | 10.57M | 7.5M | 6.73M | 7.91M |
| Total Non-Current Assets | 334.24M | 442.6M | 382.48M | 355.67M | 392.77M | 434.38M | 307.66M | 260.48M | 252.17M | 116.68M | 50.76M | 25.77M |
| Property, Plant & Equipment | 31.25M | 31.29M | 31.72M | 32.73M | 33.3M | 27.74M | 26.62M | 8.43M | 8.69M | 8.41M | 7.54M | 8.56M |
| Fixed Asset Turnover | 0.21x | 0.35x | 6.45x | - | - | 0.26x | - | - | - | 0.49x | 1.00x | 0.41x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 411.31M | 349.96M | 322.13M | 358.67M | 405.83M | 280.13M | 251.07M | 242.64M | 107.49M | 42.39M | 16.38M |
| Other Non-Current Assets | 302.99M | 0 | 805K | 805K | 805K | 805K | 911K | 986K | 849K | 782K | 827K | 830K |
| Total Assets | 1.03B | 1.11B | 1.19B | 1.04B | 1.1B | 1.12B | 1.24B | 973.66M | 961.53M | 649.32M | 532.94M | 527.56M |
| Asset Turnover | 0.01x | 0.01x | 0.19x | - | - | 0.01x | - | - | - | 0.01x | 0.02x | 0.01x |
| Asset Growth % | -6.39% | -1.31% | -4.41% | 6.94% | 14.47% | 73.12% | 132.65% | 84.56% | 163.62% | 67.36% | 29.7% | 56.08% |
| Total Current Liabilities | 64.83M | 58.81M | 64.51M | 55.34M | 50.85M | 46.07M | 40.66M | 40.74M | 24.96M | 27.1M | 24.89M | 25.34M |
| Accounts Payable | 20.74M | 17.58M | 18.43M | 17.27M | 17.63M | 15.42M | 12.57M | 15.89M | 6.29M | 6.6M | 5.17M | 5.87M |
| Days Payables Outstanding | 1.51K | - | - | - | - | 2K | 1.29K | 919.79 | 541.96 | 528.6 | 514.91 | 467.04 |
| Short-Term Debt | 350K | 339K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.44M | 2.82M |
| Other Current Liabilities | 43.74M | 29.69M | 490K | 0 | 0 | 22.12M | 0 | 0 | 13.26M | 0 | 0 | 0 |
| Current Ratio | 10.74x | 11.34x | 12.44x | 12.39x | 13.92x | 14.97x | 22.93x | 17.50x | 28.42x | 19.65x | 19.37x | 19.80x |
| Quick Ratio | 10.74x | 11.34x | 12.44x | 12.39x | 13.92x | 14.97x | 22.93x | 17.50x | 28.42x | 19.65x | 19.37x | 19.80x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 28.25M | 27.57M | 28.59M | 26.28M | 25.66M | 18.87M | 18.8M | 1.26M | 1.26M | 1.13M | 0 | 611K |
| Long-Term Debt | 28.25M | 27.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 27.57M | 26.92M | 26.28M | 25.66M | 18.87M | 18.8M | 1.26M | 1.26M | 1.13M | 0 | 611K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | -27.57M | 1.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 93.08M | 86.39M | 93.1M | 81.62M | 76.51M | 64.94M | 59.45M | 42.01M | 26.22M | 28.23M | 24.89M | 25.95M |
| Total Debt | 28.6M | 55.49M | 27.25M | 26.6M | 25.97M | 19.17M | 18.8M | 1.87M | 2.41M | 2.87M | 2.1M | 2.57M |
| Net Debt | -128.92M | -57.34M | -271.68M | -88.05M | -104.03M | -65.21M | -381.49M | -181.18M | -105.94M | -154.15M | -149.75M | -100.27M |
| Debt / Equity | 0.03x | 0.05x | 0.02x | 0.03x | 0.03x | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x |
| Debt / EBITDA | - | - | 0.25x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | -2.48x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 937.27M | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M | 621.09M | 508.05M | 501.61M |
| Equity Growth % | -8.48% | -3.42% | -7.49% | 3% | 9.5% | 70.53% | 132.34% | 85.73% | 180.19% | 77.73% | 37.77% | 86.25% |
| Book Value per Share | 10.57 | 11.55 | 12.18 | 10.85 | 11.59 | 12.13 | 13.70 | 11.95 | 12.45 | 9.52 | 8.47 | 8.92 |
| Total Shareholders' Equity | 937.27M | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M | 621.09M | 508.05M | 501.61M |
| Common Stock | 9K | 9K | 9K | 9K | 9K | 9K | 9K | 8K | 7K | 7K | 6K | 6K |
| Retained Earnings | -835.08M | -736.54M | -653.27M | -772.51M | -695.02M | -622.84M | -492.53M | -440.71M | -387.94M | -348.36M | -314.41M | -286.97M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -494K | 2.27M | 2.05M | 1.52M | 1.58M | 812K | 3.84M | -1.42M | -923K | 562K | -750K | -1.18M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |